Pre-publication history
Front-line Bevacizumab in combination with Oxaliplatin, Leucovorin and 5-Fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study
-
* Corresponding author: John Souglakos johnsougl@gmail.com
BMC Cancer 2007, 7:91 doi:10.1186/1471-2407-7-91
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 04 Dec 2006 | |
| Reviewer's Report | Jorge Aparicio | 17 Jan 2007 | |
| Reviewer's Report | Halfdan Sorbye | 29 Jan 2007 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 27 Mar 2007 |
| Reviewer's Report | Halfdan Sorbye | 20 Apr 2007 | |
| Editorial acceptance | 17 May 2007 | ||
| Published | 30 May 2007 |